Esophagogastric variceal bleeding (EVB) is a life-threatening complication of decompensated cirrhosis, with a 6-week mortality rate of 15–25% despite standardized therapeutic interventions [1,2]. Timely identification of gastroesophageal varices (GOV) and high-risk varices (HRV) is essential for optimizing outcomes in patients with chronic liver disease (CLD). To refine early identification and management of cirrhotic portal hypertension, the Baveno Ⅵ Consensus Conference [3] introduced the conc…